HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infection and transmission dynamics of rKSHV.219 in primary endothelial cells.

Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi's sarcoma (KS), a tumour of endothelial cell origin. The study of KS development was aided by the generation of a recombinant GFP (latent)/RFP (lytic)-expressing KSHV (rKSHV.219) by Vieira and O'Hearn (2004). In this study the first data characterising primary endothelial cell infection and transmission with this virus is presented. Infection was predominantly latent and the percentage of GFP-positive cells increased over time. Neither horizontal transmission of infection, nor cellular proliferation, explained this increase. Analysis of latency-associated nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP expression early post infection. At later time points GFP correlated more closely with LANA-1 expression, likely due to the accumulation of GFP over time. This study provides methodological guidance for the use of rKSHV.21. In addition, it highlights potential problems associated with the use of fluorescent proteins as markers of viral infection.
AuthorsHannah C Jeffery, Rachel L Wheat, David J Blackbourn, Gerard B Nash, Lynn M Butler
JournalJournal of virological methods (J Virol Methods) Vol. 193 Issue 1 Pg. 251-9 (Oct 2013) ISSN: 1879-0984 [Electronic] Netherlands
PMID23764419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Green Fluorescent Proteins
Topics
  • Cells, Cultured
  • Endothelial Cells (virology)
  • Fluorescence
  • Green Fluorescent Proteins (analysis, genetics)
  • Herpesvirus 8, Human (growth & development, physiology)
  • Humans
  • Staining and Labeling (methods)
  • Time Factors
  • Virology (methods)
  • Virus Latency
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: